Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

Clinical trial NCT00060125 · COMPLETED

Trial details

NCT number: NCT00060125
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma

Start date: 2003-05-01
Primary completion: 2006-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.